These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19785620)

  • 1. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006.
    Naldi L; Svensson A; Zenoni D; Diepgen T; Elsner P; Grob JJ; Coenraads PJ; Bouwes Bavinck JN; Maccagni A; Linder D; Williams H;
    Br J Dermatol; 2010 Feb; 162(2):384-9. PubMed ID: 19785620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship.
    Manalo IF; Gilbert KE; Wu JJ
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1945-50. PubMed ID: 25763768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?
    Morsy H; Kamp S; Jemec GB
    J Dermatolog Treat; 2007; 18(5):261-7. PubMed ID: 17917937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trials for psoriasis 1977-2000: the EDEN survey.
    Naldi L; Svensson A; Diepgen T; Elsner P; Grob JJ; Coenraads PJ; Bavinck JN; Williams H;
    J Invest Dermatol; 2003 May; 120(5):738-41. PubMed ID: 12713574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of randomized controlled trials published in the US family medicine literature, 1987-1991.
    Silagy CA; Jewell D; Mant D
    J Fam Pract; 1994 Sep; 39(3):236-42. PubMed ID: 8077902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
    Yuen SY; Pope JE
    Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between research sponsorship and study outcome in plastic surgery literature.
    Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
    Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
    Flytström I; Stenberg B; Svensson A; Bergbrant IM
    Br J Dermatol; 2008 Jan; 158(1):116-21. PubMed ID: 17986302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the randomized controlled trial in oncology over three decades.
    Booth CM; Cescon DW; Wang L; Tannock IF; Krzyzanowska MK
    J Clin Oncol; 2008 Nov; 26(33):5458-64. PubMed ID: 18955452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.
    Ali FM; Cueva AC; Vyas J; Atwan AA; Salek MS; Finlay AY; Piguet V
    Br J Dermatol; 2017 Mar; 176(3):577-593. PubMed ID: 27273146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The end of the primary outcome measure: a research agenda for constructing its replacement.
    De Los Reyes A; Kundey SM; Wang M
    Clin Psychol Rev; 2011 Jul; 31(5):829-38. PubMed ID: 21545781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice.
    Chalmers RJ
    Dermatol Clin; 2015 Jan; 33(1):57-71. PubMed ID: 25412783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.